edrecolomab

BIOLOGICAL2 trials

Conditions

Colorectal CancerMucinous Adenocarcinoma of the ColonSignet Ring Adenocarcinoma of the ColonStage IIA Colon CancerStage IIB Colon CancerStage IIC Colon Cancer

Phase 2

Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer

WithdrawnNCT00002664

James AhlgrenColorectal Cancer

Start: 1995-07-31End: 2017-02-22Updated: 2017-07-13

Phase 3

Edrecolomab in Treating Patients With Stage II Colon Cancer

CompletedNCT00002968

National Cancer Institute (NCI)Mucinous Adenocarcinoma of the Colon, Signet Ring Adenocarcinoma of the Colon, Stage IIA Colon Cancer +2

Start: 1997-05-01Updated: 2026-06-01

edrecolomab

Sponsors

Conditions

Phase 2

Phase 3